SCHEMBL30983852

SCHEMBL30983852

Cc1ccnc(Cn2cnc3c(OC4(C)CC4)ncnc32)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ RECQL P46063 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ SCN9A Q15858 2/20 0.40
▸ KCNH2 Q12809 1/20 0.40
▸ SCN5A Q14524 1/20 0.40
▸ DAPK1 P53355 1/20 0.40
▸ HPGD P15428 1/20 0.38
▸ FLT4 P35916 1/20 0.36
▸ KDR P35968 1/20 0.36
▸ PDE8A O60658 3/20 0.36
▸ PIK3CD O00329 2/20 0.35
▸ GALR3 O60755 1/20 0.35
▸ NR2F2 P24468 1/20 0.35
▸ PDE10A Q9Y233 1/20 0.34
▸ LMNA P02545 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ HRH4 Q9H3N8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30983894 0.78 DAPK1 (0.65) HTTSCN9ADAPK1HPGDFLT4
SCHEMBL30983811 0.74 DAPK1 (0.62) HTTSCN9ADAPK1HPGDFLT4
SCHEMBL30983919 0.74 DAPK1 (0.47) MEN1HTTRECQLKMT2ANPSR1
SCHEMBL31269215 0.74 KCNH2 (0.34) MEN1HTTRECQLKMT2ANPSR1
SCHEMBL30983779 0.74 KCNH2 (0.36) SCN9AKCNH2SCN5APIK3CD
SCHEMBL30983829 0.74 KCNH2 (0.34) SCN9AKCNH2SCN5APIK3CDPDE10A
SCHEMBL31269114 0.72 DAPK1 (0.60) HTTSCN9ADAPK1HPGDFLT4
SCHEMBL30984045 0.72 DAPK1 (0.43) MEN1HTTRECQLKMT2ANPSR1
SCHEMBL31269054 0.72 KCNH2 (0.34) SCN9AKCNH2SCN5APIK3CDPDE10A
SCHEMBL30983905 0.68 HDAC1 (0.45) MEN1KMT2ASCN9AKCNH2SCN5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630410-A1 POLQ INHIBITORS Astrazeneca AB (SE) 2025-10-15 — — EP disclosed
WO-2024121753-A1 POLQ INHIBITORS ASTRAZENECA AB (SE) 2024-06-13 — — WO disclosed
Send feedback